Distinguishing between adverse and non-adverse effects. Session summary.
Karbe
E
E
NYMC, Dept. Pathology, Valhalla, USA. eberhard.karbe@t-online.de
Williams
G M
GM
Lewis
R W
RW
Kimber
I
I
Foster
P M D
PM
D000222:Adaptation, Physiological; D000818:Animals; D003226:Congresses as Topic; D004702:Endocrine Glands / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000503:physiopathology; D019055:No-Observed-Adverse-Effect Level; D010336:Pathology / Q000379:methods / Q000639:trends; D018570:Risk Assessment; D012958:Societies, Scientific; D014116:Toxicology / Q000379:methods / Q000639:trends; D015262:Xenobiotics / Q000009:adverse effects*
D015262:Xenobiotics